News

Bellvitge leads the creation of a new, more precise tool to assess chemotherapy-induced neurological toxicity

IDIBELL, HUB and ICO have led a European study that presents an innovative tool to assess chemotherapy-induced peripheral neuropathy (CIPN). The great advantage of this system is that it incorporates the patient’s perception, an aspect that until now medical scales did not adequately take into account.

Leer más about Bellvitge leads the creation of a new, more precise tool to assess chemotherapy-induced neurological toxicity

A new personalized therapy through genomic profiling may improve survival in patients with cancer of unknown primary

The CUPISCO study, the largest to date on cancer of unknown primary, reveals that molecularly guided therapy is more effective than standard chemotherapy in cancer cases with an unfavorable prognosis.

Leer más about A new personalized therapy through genomic profiling may improve survival in patients with cancer of unknown primary

Iron accumulation and cellular senescence in liver fibrosis: new perspectives on treatment

Researchers from IDIBELL, CIC bioGUNE, CIBEREHD and IRB Barcelona demonstrate that iron accumulation is an important factor in the progression of liver fibrosis and cellular senescence. The study suggests that the administration of iron chelators could be an effective strategy to slow down or prevent liver fibrosis.

Leer más about Iron accumulation and cellular senescence in liver fibrosis: new perspectives on treatment

Advances in chemical biology are fueled by multidisciplinarity and teamwork

Dr Albert Antolin from IDIBELL and ICO highlights the relevance of multidisciplinarity and teamwork for the advance of chemical biology research, a field that is opening new paths in drug discovery and precision medicine.

Leer más about Advances in chemical biology are fueled by multidisciplinarity and teamwork

Neuroscientist Ernest Arenas passes away

Arenas was a member of the IDIBELL Scientific Advisory Board.

Leer más about Neuroscientist Ernest Arenas passes away

Dr. Maria Molina, IDIBELL scientific director, receives the European Respiratory Society Gold Medal

Dr. Molina has received one of the ERS Mid-Career Gold Medals Award, which recognizes both an already consolidated outstanding research career and the work potential still ahead of a respiratory diseases specialist.

Leer más about Dr. Maria Molina, IDIBELL scientific director, receives the European Respiratory Society Gold Medal

For the first time, scientists link air pollution to the use of antibiotics

A research group from IDIBELL just published in JAMA Network Open the first article linking these two phenomena: based on a complete statistical analysis, scientists have found that on those days when air pollution increases the most, more antibiotics are prescribed.

Leer más about For the first time, scientists link air pollution to the use of antibiotics

SpadaHC, a new database to improve hereditary cancer genes variants classification in the Spanish population

The tool, developed by IDIBELL, ICO and CIBERONC researchers, facilitates a more precise and uniform genetic variants classification, a key to making clinical decisions in patients with suspected cancer and to improving attention to patients and their families

Leer más about SpadaHC, a new database to improve hereditary cancer genes variants classification in the Spanish population

Bellvitge co-leads an international trial that can change the treatment of heart failure

Published in the New England Journal of Medicine, this trial has confirmed the benefits of a drug, finerenone, in an important segment of heart failure cases. The study included more than 6,000 patients from 50 countries and, in Spain it has been coordinated by IDIBELL and Bellvitge Hospital.

Leer más about Bellvitge co-leads an international trial that can change the treatment of heart failure
Scroll to Top